SuperworthFirefly Neuroscience shares outstanding AIFF
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Sep 30, 2025
- 13.5M
- On a year earlier
- +90.6%
- more shares
Firefly Neuroscience had 13.5M diluted shares outstanding on average in Q3 FY25, the quarter to Sep 30, 2025.
That is 90.6% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2021 | 1.4M | +13% |
| FY2020 | 1.3M | +14% |
| FY2019 | 1.1M | +0% |
| FY2018 | 1.1M | −5% |
| FY2017 | 1.2M | +5% |
| FY2016 | 1.1M | −1% |
| FY2015 | 1.1M | +1% |
| FY2014 | 1.1M | +0% |
| FY2013 | 1.1M | −0% |
| FY2012 | 1.1M | −0% |
| FY2011 | 1.1M | +0% |
| FY2010 | 1.1M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q3 FY25 | 13.5M | +91% | |
| Q3 FY24 | 7.1M | n/a | |
| Q2 FY24 | 671.1K | +3% | |
| Q2 FY23 | 648.5K | −63% | |
| Q3 FY22 | 1.8M | +46% | |
| Q2 FY22 | 1.7M | +37% | |
| Q1 FY22 | 1.7M | +41% | |
| Q4 FY21 | 1.4M | +13% | |
| Q3 FY21 | 1.3M | +6% | |
| Q2 FY21 | 1.3M | +13% | |
| Q1 FY21 | 1.2M | +10% | |
| Q4 FY20 | 1.3M | +14% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Firefly Neuroscience
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.